Covalent inhibitors are a specialized class of small molecules designed to form chemical bonds with their target proteins, often resulting in prolonged target engagement and enhanced potency. The ...

Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor over the line for inflammatory diseases that have been historically difficult ...

This video explores the limits of cutting paper, focusing on its primary component, cellulose. It analyzes the types of bonds ...

Numerous applications of phenolic compounds, a large family of naturally occurring molecules, in biosensing, bioimaging, and disease treatment can not be ...